LONDON BROKER RATINGS: Citi resumes at Aviva at 'neutral'
(Alliance News) - The following London-listed shares received analyst recommendations Tuesday morning and on Monday: Read More
Price | 383.00p on 25-07-2025 | at 18:30:07
---|---|
Change | -3.50p -0.91% |
Buy | 384.50p |
Sell | 381.00p |
Last Trade: | Buy 306.00 at 383.00p |
Day's Volume: | 66,975 |
Last Close: | 383.00p |
Open: | 388.50p |
ISIN: | GB00BDFBVT43 |
Day's Range | 380.00p - 389.50p |
52wk Range: | 232.50p - 455.00p |
Market Capitalisation: | £406.50m |
VWAP: | 385.83346p |
Shares in Issue: | 106.14m |
Oxford Biomedica (OXB) Latest Trades |
||||
Buy/Sell | Volume | Trade Prc | Trade Type | Trade Time |
---|---|---|---|---|
Buy* | 306 | 383.00p | Automatic Execution |
16:35:24 - 25-Jul-25 |
Sell* | 93 | 383.00p | Automatic Execution |
16:35:24 - 25-Jul-25 |
Sell* | 8,052 | 383.00p | Uncrossing Trade |
16:35:24 - 25-Jul-25 |
Sell* | 45 | 382.00p | Automatic Execution |
16:29:51 - 25-Jul-25 |
Sell* | 2 | 382.00p | Automatic Execution |
16:29:27 - 25-Jul-25 |
Sell* | 1,200 | 383.31p | Ordinary |
16:25:25 - 25-Jul-25 |
Sell* | 72 | 384.50p | Automatic Execution |
16:21:59 - 25-Jul-25 |
Sell* | 104 | 384.50p | Automatic Execution |
16:21:59 - 25-Jul-25 |
Sell* | 46 | 384.50p | Automatic Execution |
16:21:59 - 25-Jul-25 |
Sell* | 65 | 385.00p | Automatic Execution |
16:20:19 - 25-Jul-25 |
Oxford Biomedica (OXB) Regulatory News |
||
Date | Source | Headline |
---|---|---|
2nd Jul 2025 7:00 am | RNS | Director Declaration |
1st Jul 2025 7:00 am | RNS | Block listing Interim Review |
1st Jul 2025 7:00 am | RNS | Total Voting Rights |
23rd Jun 2025 7:00 am | RNS | OXB completes acquisition of US subsidiary |
17th Jun 2025 6:00 pm | RNS | Director/PDMR Shareholding |
11th Jun 2025 6:02 pm | RNS | Result of Annual General Meeting |
11th Jun 2025 7:02 am | RNS | AGM Update |
10th Jun 2025 10:49 am | RNS | Holding(s) in Company |
5th Jun 2025 7:00 am | RNS | Block Listing Application |
3rd Jun 2025 7:00 am | RNS-R | OXB Launches Advisory Board |